About Us
NeuralCloud Solutions Inc. builds per-beat ECG analysis. We are a fully owned subsidiary of AI/ML Innovations (CSE: AIML), with teams in Toronto and Calgary and a medical advisory board that works on the product rather than beside it.
What we do
NeuralCloud Solutions Inc. builds per-beat ECG analysis. MaxYield analyzes ambulatory ECG and returns PQRST delineation, intervals, rhythm classification and per-beat signal quality, structured for research and investigational use. BodyOS visualizes and reports on that output.
Our Team
Chief Executive Officer - AI/ML Innovations
Chief Operating Officer - AI/ML Innovations
President & Chief Product Officer - NeuralCloud Solutions
Chief Technology Officer - NeuralCloud Solutions
Chief Operating Officer - NeuralCloud Solutions
VP, Marketing & Revenue Operations - NeuralCloud Solutions
Chief AI Officer - NeuralCloud Solutions
Chief Creative Officer - NeuralCloud Solutions
Medical Advisory Board
The competitive moat you cannot buy. Two of the world’s most credentialed cardiac electrophysiologists don’t just advise - they co-develop the algorithm & personally label the datasets
Dr. Paul Dorian
MD, MSc, FRCPC, FACC — Head of the Medical Advisory Board, AI/ML Innovations Inc.; Professor of Medicine, Cardiology & Pharmacology, University of Toronto; Staff Scientist at the Li Ka Shing Knowledge Institute; Staff Cardiac Electrophysiologist at St. Michael’s Hospital
Professor of Medicine, U of Toronto; Staff Cardiac Electrophysiologist at St. Michael’s Hospital. Founded the EP program there in 1990; past President of the Canadian Heart Rhythm Society. 580+ peer-reviewed papers.
Dr. Martin Stephen Green
MD, FRCPC — Professor Emeritus, Faculty of Medicine, University of Ottawa; recently retired Cardiologist and Cardiac Electrophysiologist at the University of Ottawa Heart Institute (UOHI)
Professor Emeritus, University of Ottawa; a founding figure of Canadian cardiac electrophysiology. Established the Arrhythmia Service at the University of Ottawa Heart Institute in 1983 and built it into a national referral centre.
Dr. Alan Rabinowitz
MBChB, FRCPC, FACC — Chief Medical Officer, AIML; Cardiologist and formerly Director of the Coronary Care Unit, St. Paul’s Hospital Heart Centre / Centre for Heart Lung Innovation; Clinical Associate Professor, Division of Cardiology, University of British Columbia
Cardiologist and Clinical Associate Professor at St. Paul’s Hospital, UBC. Serves on the CCS AI Advisory Committee; former Director of the Cardiac Intensive Care Unit at St. Paul’s.
Dr. Kim Connelly
MBBS, PhD, FRACP, FRCPC — Professor of Medicine and Physiology, University of Toronto; Cardiologist and Scientist, St. Michael’s Hospital
Professor of Medicine and Physiology, University of Toronto; Cardiologist-Scientist at St. Michael’s Hospital, directing the Cardio-Metabolic Research Program. Integrates ML biomarkers with MRI and echo phenotyping; $15M+ in competitive funding.
Dr. Brett Heilbron
MBChB, FRCPC, FACC — Medical Director, Electrodiagnostics Program; Clinical Associate Professor, Division of Cardiology, University of British Columbia; St. Paul’s Hospital Heart Centre, Vancouver, BC
Medical Director of the Electrodiagnostics Program at St. Paul’s and Mount St. Joseph’s Hospital; Clinical Associate Professor at UBC. Cardiology consultant for LifeLabs BC; Level 3 Certification in Cardiac CT.
Dr. Marc W. Deyell
MD, MSc, FHRS, FCCS — Clinical Professor, University of British Columbia; Director, Heart Rhythm Services, St. Paul’s Hospital
Clinical Professor at UBC and Director of Heart Rhythm Services at St. Paul’s Hospital. Work spans VT ablation and inherited arrhythmic syndromes; supervises first-in-human trials of AI-driven ECG analytics underpinning MaxYield validation.
Board of Directors
Independent governance with deep public-markets and regulated-industry experience - ensuring the company scales responsibly across regulated cardiology markets.
Paul Duffy
Executive chairman & CEO
30+ years commercializing digital technologies, with prior leadership at NexTech3D.AI and ARHT Media. Serves as Executive Chairman, driving the AIML mission.
LinkedIn
Jared Adelstein
Independent director
Nearly a decade in investment banking and capital markets advising high-growth early-stage companies in Toronto. Expertise in forecasting, operational planning, and capital raising.
Michael Diamond
Independent director
Principal of Upstream Strategy Group and President of the Ontario Progressive Conservative Party. Brings political-strategy and regulatory-affairs expertise, aligning innovation with government priorities.
It started with a de-noising algorithm that worked.
The founding team of signal processing experts, leveraging the supercomputer at the University of Alberta, set out to build better de-noising for wearable ECG.
They succeeded - and discovered their own de-noising was cancelling real cardiac signal alongside the artifact. Every filtering step is a step where physiology can be removed with the noise.
So the architecture changed. Instead of removing noise before measuring, MaxYield learns the waveform well enough to locate its boundaries within a noisy trace, and measures against what was actually recorded.
Put MaxYield underneath
what you already run.
Your algorithm starts from R-wave triggered data. MaxYield gives it resolved QRS boundaries, P-wave delineation where detected, per-beat intervals, and a quality score alongside every measurement it returns. You are not replacing what you built. You are raising its floor.